Inventor
Darrin Anthony Lindhout
Inventor
Mountain View, CA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
C07KPeptides32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes3%
PatentTitleYear
11,066,454Compositions comprising variants and fusions of FGF19 polypeptides202111,065,302Compositions comprising fusion variants of FGF19 polypeptides202110,869,909Compositions and methods of use for treating metabolic disorders202010,758,590Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetes202010,610,568Compositions and methods of use for treating metabolic disorders202010,562,965Compositions and methods of use for treating metabolic disorders202010,517,929Pharmaceutical compositions comprising FGF19 variants201910,413,590Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject201910,398,758Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions201910,323,075Compositions and methods of use for treating metabolic disorders201910,195,250Compositions and methods of use for treating metabolic disorders20199,963,494Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject20189,920,118'Compositions and methods of use for treating metabolic disorders'20189,834,586Compositions and methods of use for treating metabolic disorders20179,828,415Compositions and methods of use for treating metabolic disorders20179,827,291Compositions and methods of use for treating metabolic disorders20179,751,924'Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subject'20179,670,260'Compositions comprising fusion variants of FGF19 polypeptides'20179,580,483'Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetes'20179,550,819'Compositions and methods of use for treating metabolic disorders'20179,290,557'Compositions comprising variants and fusions of FGF19 polypeptides'20169,161,966'GDF15 mutein polypeptides'20159,089,525'Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject'20158,951,966'Compositions comprising variants and fusions of FGF19 polypeptides, and uses and methods thereof for treatment of metabolic disorders and diseases'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2021Patents assigned to NGM BIOPHARMACEUTICALS INC (24)· patent assignee history
2015Patents assigned to LINDHOUT DARRIN A (1)· patent assignee history
2015Patents assigned to LING LEI (1)· patent assignee history
2015–2021Based in Mountain View, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 24 | 2015–2021 |
| LINDHOUT DARRIN Aself | 1 | 2015 |
| LING LEI | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mountain View, California, US | 24 | 2015–2021 |